Coeliac disease vaccine trials

MEDIA ARTICLECoffee Hops21 January 2019

The vaccine aims to protect patients from the harmful effects of gluten

A WORLD-FIRST coeliac disease vaccine is being tested which aims to end the need for gluten-free diets.

Shireen Khalil, news.com.au

MEDIA ARTICLECoffee Hops21 January 2019

Vaccine for coeliac disease being trialled at Australian hospitals

www.adelaidenow.com.au

MEDIA ARTICLECoffee Hops21 January 2019

The research that could end Coeliac disease

The Chronicle, by Shireen Khalil

MEDIA ARTICLECoffee Hops31 October 2018

ImmusanT Initiates Phase 2 Enrollment for its Lead Therapeutic Vaccine Candidate in Patients With Celiac Disease in Australia and New Zealand

ImmusanT, Inc., a clinical stage company leveraging its Epitope-Specific Immuno-Therapy™ (ESIT™) platform to deliver first-in-class peptide-based immunomodulatory vaccine therapies to patients with autoimmune diseases, initiated enrollment in Australia and New Zealand for its Phase 2 RESET CeD study assessing the safety, tolerability and efficacy of its lead therapeutic candidate, Nexvax2®, in patients with celiac disease who carry the immune recognition genes for HLA-DQ2.5.

MEDIA RELEASECoffee Hops30 October 2018